Deutsche Bank Maintains Buy on HCA Healthcare, Raises Price Target to $359
Portfolio Pulse from Benzinga Newsdesk
Deutsche Bank analyst Pito Chickering has maintained a Buy rating on HCA Healthcare (NYSE:HCA) and increased the price target from $330 to $359.
April 12, 2024 | 4:50 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Deutsche Bank maintains a Buy rating on HCA Healthcare and raises the price target to $359.
The upgrade in the price target by a reputable analyst like Pito Chickering from Deutsche Bank is a strong positive signal for HCA Healthcare. It suggests confidence in the company's future performance and growth prospects, likely leading to increased investor interest and potentially a rise in the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100